Hypertension Research 26 Evaluation of balloonIn tamponade

ORIGINAL ARTICLE Reprint request to: Takashi Yorifuji, M.D., Ph.D., Department of Obstetrics and Gynecology, Juntendo University Evaluation of the effectiveness of Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, metreurynters for balloon Japan. tamponade E-mail: [email protected] Key words: balloon tamponade, Takashi Yorifuji, Jun Takeda, Shintaro Makino, Toshitaka Tanaka, extravasation, metreurynter, non-inferiority, postpartum Atsuo Itakura, Satoru Takeda hemorrhage

Received: January 17, 2018 Department of Obstetrics and Gynecology, Juntendo University, Faculty of Medicine, Revised: June 12, 2018 Tokyo, Japan Accepted: June 12, 2018 J-STAGE Advance published date: July 31, 2018

DOI:10.14390/jsshp.HRP2018-001

Aim: Several devices are used for balloon tamponade. In Japan, metreurynters are widely used for cervical ripening; however, there is little evidence for their use in hemostatic uterine balloon tamponade. This study aimed to assess the non-inferiority of metreurynters as the balloon device for obstetric hemorrhage. Methods: Medical charts of all patients with obstetric hemorrhage of more than 1,000 ml who underwent balloon tamponade with metreurynters were retrospectively reviewed for five years at a tertiary referral university hospital. Results: A total of 89 uterine balloon tamponade cases were identified from medical records. Of these, 66 cases involved term postpartum hemorrhage (PPH) within 24 h after delivery (PPH group) and 23 involved other types of cases (other group), including cesarean scar pregnancy, , retained placenta, and others. In the PPH group, the average hemostasis rate was 93.9%, whereas the rate was 91.3% in the other group. Seven cases failed to achieve hemostasis with balloon tamponade only and required additional treatment. There were no adverse events related to balloon tamponade using metreurynters. Conclusions: Metreurynters used for balloon tamponade were non-inferior to Bakri balloons in hemostasis and complication rates, suggesting they are effective and appropriate for the management of obstetrical hemorrhage.

Introduction gauze. Subsequently, uterine balloon tamponade was introduced as a modality for treating PPH. Various types Obstetric hemorrhage is a life-threatening event that of balloon catheters have been introduced, including the can lead to postpartum hemorrhage (PPH), traditionally Bakri balloon,1) the Sangstaken-Blakemore esophageal defined as bleeding of more than 500 ml. PPH accounts catheter,2,3) the Rush urological balloon,4,5) various for a large proportion of maternal deaths worldwide, as condom catheters,6,7) and the Foley balloon catheter.1,8) well as in Japan. Since PPH can quickly lead to maternal Obstetricians now typically prefer intrauterine balloons morbidity, it requires rapid and appropriate treatment. to uterine packing in order to manage PPH.9) Indeed, the Other than PPH, post hemorrhage, cesarean scar Japan Association of Obstetricians and Gynecologists pregnancy (CSP), and cervical (CP) recommends a balloon tamponade test for PPH.10) are also potentially life-threatening events. Furthermore, organizations such as the World Health In cases of massive obstetrical hemorrhage, Organization (WHO),11) the International Federation conventional methods such as bimanual uterine of Gynecology and Obstetrics (FIGO),12) the American compression and administration of uterotonic agents are Congress of Obstetricians and Gynecologists (ACOG),13) used to achieve hemostasis. When these methods fail, and the Royal College of Obstetricians and Gynaecologists the historical approach of using a tamponade effect to (RCOG)14) have recommended intrauterine balloons as control PPH involved packing the with sterile the first-line hemostatic treatment for PPH.

26 Hypertens Res Pregnancy 2018; 6: 26–29 Hypertension Research in Pregnancy © 2018 Japan Society for the Study of Hypertension in Pregnancy T. Yorifuji et al.

In Japan, metreurynters are widely used to induce was removed about 24 h after insertion. During this time, labor15) and for mechanical maturation of the . uterotonic drugs were also administered. Thus, Japanese obstetricians are accustomed to handling Prior to balloon tamponade, verbal informed consent metreurynters, which are commonly used at delivery was obtained in every case following an explanation of facilities. However, no studies have addressed their the situation and the necessity for intrauterine balloon effectiveness as balloons for intrauterine tamponade. tamponade. Accordingly, this study retrospectively assessed hemostasis outcomes and ineffective hemostasis cases Results in order to clarify the hemostatic effect of metreurynters. A total of 89 cases were identified from medical records. Materials and methods There were 66 cases in the PPH group in which balloon tamponade was used within 24 h after delivery, and 23 At our institution, metreurynters (Fuji-Metro; Fuji Latex cases in the other group, including CSP, CP, retained Co., Ltd., Tochigi, Japan and Mini-Metro; Soft Medical placenta, and others. Co., Ltd., Tokyo, Japan) have been used as balloons for Table 1 shows the details of bleeding amount within intrauterine tamponade since April 2009 for first-line 24 h after delivery, hemostasis success rate, and amount mechanical hemostasis of PPH. A retrospective review of balloon inflation in the PPH group. There was one of medical charts of all patients who underwent balloon case of acute fatty liver of pregnancy with disseminated tamponade with metreurynters between April 2009 intravascular coagulation (DIC). Three other cases and April 2014 at Juntendo University Hospital was were followed; two cases of recurrent bleeding after conducted. Hemostasis success rate, volume of balloon transcatheter arterial embolization (TAE) and one case inflation, and patient characteristics were assessed. of pregnancy with idiopathic thrombocytopenic purpura Hemostasis rate was considered the primary outcome, (ITP). The mean hemostasis rate was 93.9%, and the and complication rate was considered the secondary median amount of balloon inflation was 120 ml (80 to outcome. 150 ml). This study was approved by the Clinical Investigation Table 2 provides the details of bleeding amount, Ethics Committee of Juntendo University. hemostasis success rate, and amount of balloon inflation for the other group. Among cases of retained placenta, Balloon tamponade bleeding for more than 24 h after delivery was observed For cases of persistent massive hemorrhage ( > 1,000 in three cases in the first and second trimesters, and ml) even after conventional treatments such as bimanual eight cases in the third trimester. Three other cases were uterine compression and administration of uterotonic followed, including two cases of atonic bleeding after agents, a balloon tamponade test was performed as in the second trimester and one case of follows. A metreurynter was used as the balloon device, in the second trimester. The mean except in cases of latex allergy. Based on the volume of hemostasis rate was 91.3%. The median amount of the uterine cavity, two metreurynters were available: the balloon inflation was 15 ml in the first trimester (10to Fuji-Metro, with a maximum volume of 150 ml, and the 35 ml), 40 ml in the second trimester (20 to 40 ml), and Mini-Metro for cervical ripening, which has a maximum 40 ml in the third trimester (10 to 120 ml). volume of 40 ml. There were four and two cases of balloon tamponade With transabdominal ultrasound guidance, the balloon failure in the PPH group and the other group, respectively. was inserted into the uterine cavity as a balloon catheter Table 3 shows the details of these cases. A second surgery and inflated with enough saline to both prevent the was performed for a case with ruptured sutures post- device from falling into the and to achieve cesarean section, and complete hemostasis was achieved hemostasis. For cesarean section cases, metreurynters in the remaining five cases after TAE. There were no pre-inflated with 50 ml of sterile saline were inserted into adverse events related to balloon tamponade using the lower uterine segment from the incision site of the metreurynters. uterus with the shafts passed through the cervical canal. Subsequently, the balloon was inflated with 50–150 ml Discussion of saline vaginally until hemostasis was achieved, after closure of the uterine incision. A satisfactory hemostasis rate with balloon tamponade After insertion of the balloon, vital signs and vaginal was achieved using metreurynters in the PPH group, bleeding were serially monitored. Moreover, the absence which is consistent with previous reports.16,17) This of retained lochia or intrauterine hematoma was success rate was similar to rates with other treatment confirmed by transabdominal ultrasound. The balloon methods, including embolization and uterine compression

Hypertens Res Pregnancy 2018; 6: 26–29 27 Evaluation of balloon tamponade

Table 1. PPH group ( < 24 h after delivery) Hemostasis rate (%) Balloon inflation [range] ml Atonic bleeding, n = 32 100 120 [80–150] Placenta previa/low-lying placenta, n = 16 100 120 [80–140] Isthmus laceration, n = 11 100 120 [80–140] Retained placenta, n =2 0 130 [120–140] Acute fatty liver of pregnancy, n =1 0 80 Ruptured suture post-cesarean section, n =1 0 150 Others, n =3 100 120 [100–120]

Table 2. Other group Hemostasis rate (%) Balloon inflation [range] ml Cesarean scar/cervical pregnancy, n =9 88.8 20 [10–35] Retained placenta, n = 11 90.9 35 [8–120] First and second trimester, n =3 100 15 [8–40] Third trimester (≥ 24 h after delivery), n =8 87.5 35 [15–120] Others, n =3 100 40 [20–70]

Table 3. Cases that failed the balloon tamponade test and required additional treatment Ineffective hemostasis cases Additional treatment PPH group n =4 Ruptured suture Hemostatic laparotomy Retained placenta TAE + D&C Retained placenta TAE + D&C Acute fatty liver of pregnancy TAE

Other group n =3 Retained placenta TAE Scar pregnancy TAE Abbreviations: PPH, postpartum hemorrhage; TAE, transcatheter arterial embolization; D&C, dilatation and curettage sutures.18) In addition, the present hemostasis results Moreover, the Bakri balloon is priced at JPY29000, using small metreurynters are consistent with previous whereas metreurynters cost JPY3200 for the Fuji-metoro studies showing the effectiveness of Foley balloon and JPY1500 for the Mini-metro. Thus, metreurynters are catheters for local treatment of CSP and CP.19,20) substantially less expensive than Bakri balloons. With regard to the volume of balloon inflation, different volumes have been reported depending on balloon shape: Conclusion Bakri, 500 ml;21) Sengstaken-Blakemore, 120–370 ml;22) Rusch, 240–1,000 ml;23) and Condom, 200–500 ml.6) Metreurynters used for balloon tamponade were non- The required volumes of saline depend on both balloon inferior to Bakri balloons in terms of hemostasis shape and uterine capacity. In the PPH group, cases of success and complication rates, and are substantially atonic bleeding, placenta previa/low-lying placenta, less expensive. Our findings suggest that metreurynters and incomplete laceration of the isthmus, where 100% are effective and appropriate for the management of hemostasis rates were achieved, required a median obstetrical hemorrhage. volume of only 120 ml, suggesting that less saline than required for the Bakri balloon was sufficient to achieve Acknowledgements hemostasis. These findings were supported by Georgiou who demonstrated a curvilinear relationship between None. intraluminal pressure and balloon volume, with only a small amount of saline required to achieve hemostasis.24)

28 Hypertens Res Pregnancy 2018; 6: 26–29 T. Yorifuji et al.

Conflict of Interest 117: 108–118. 13. American College of Obstetricians and Gynecologists (ACOG). None. Clinical management guidelines for obstetrician-gynecologists: postpartum hemorrhage. ACOG Practice bulletin No. 76. Obstet Gynecol. 2006; 108: 1039–1047. References 14. Royal College of Obstetrician and Gynaecologists (RCOG). Postpartum hemorrhage: prevention and management. Green-top 1. Bakri YN. Uterine tamponade-drain for hemorrhage secondary to Guideline No. 52. 2011. placenta previa-accreta. Int J Gynaecol Obstet. 1992; 37: 302–303. 15. Matsumoto N, Osada M, Matsumoto C, et al. Labor induction 2. Sengstaken RW, Blakemore AH. Balloon tamponage for the using modified metreurynters plus oxytocin at an institution in control of hemorrhage from esophageal varices. Ann Surg. 1950; Japan: a retrospective study. Clin Exp Obstet Gynecol. 2014; 41: 131: 781–789. 10–16. 3. Ishii T, Sawada K, Koyama S, et al. Balloon tamponade during 16. Georgiou C. Balloon tamponade in the management of postpartum cesarean section is useful for severe post-partum hemorrhage due haemorrhage: a review. BJOG. 2009; 116: 748–757. to placenta previa. J Obstet Gynaecol Res. 2012; 38: 102–107. 17. Revert M, Cottenet J, Raynal P, Cibot E, Quantin C, Rozenberg 4. Johanson R, Kumar M, Obhrai M, Young P. Management of P. Intrauterine balloon tamponade for management of severe massive postpartum haemorrhage: use of a hydrostatic balloon postpartum haemorrhage in a perinatal network: a prospective catheter to avoid laparotomy. BJOG. 2001; 108: 420–422. cohort study. BJOG. 2017; 124: 1255–1262. 5. Ferrazzani S, Iadarola R, Perrelli A, et al. Use of an intrauterine 18. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic inflated catheter balloon in massive post-partum hemorrhage: a review of conservative management of postpartum hemorrhage: series of 52 cases. J Obstet Gynaecol Res. 2014; 40: 1603–1610. what to do when medical treatment fails. Obstet Gynecol Surv. 6. Akhter S, Begum MR, Kabir Z, Rashid M, Laila TR, Zabeen 2007; 62: 540–547. F. Use of a condom to control massive postpartum hemorrhage. 19. Jiang T, Liu G, Huang L, Ma H, Zhang S. Methotrexate therapy MedGenMed. 2003; 5: 38. followed by suction curettage followed by Foley tamponade for 7. Akhter S, Begum MR, Kabir J. Condom hydrostatic tamponade for caesarean scar pregnancy. Eur J Obstet Gynecol Reprod Biol. 2011; massive postpartum hemorrhage. Int J Gynaecol Obstet. 2005; 90: 156: 209–211. 134–135. 20. Timor-Tritsch IE, Cali G, Monteagudo A, et al. Foley balloon 8. De Loor JA, van Dam PA. Foley catheters for uncontrollable catheter to prevent or manage bleeding during treatment for obstetric or gynecologic hemorrhage. Obstet Gynecol. 1996; 88: cervical and Cesarean scar pregnancy. Ultrasound Obstet Gynecol. 737. 2015; 46: 118–123. 9. Lone F, Sultan AH, Thakar R, Beggs A. Risk factors and 21. Bakri YN1, Amri A, Abdul Jabbar F. Tamponade-balloon for management patterns for emergency obstetric over 2 . Int J Gynaecol Obstet. 2001; 74: 139–142. decades. Int J Gynaecol Obstet. 2010; 109: 12–15. 22. Seror J, Allouche C, Elhaik S. Use of Sengstaken-Blakemore tube 10. Takeda S, Makino S, Takeda J, et al. Japanese Clinical Practice in massive postpartum hemorrhage: a series of 17 cases. Acta Guide for Critical Obstetrical Hemorrhage (2017 revision). J Obstet Gynecol Scand. 2005; 84: 660–664. Obstet Gynaecol Res. 2017; 43: 1517–1521. 23. Keriakos R, Mukhopadhyay A. The use of the Rusch balloon 11. World Health Organization (WHO). WHO recommendations for for management of severe postpartum haemorrhage. J Obstet the prevention and treatment of postpartum haemorrhage. Geneva: Gynaecol. 2006; 26: 335–338. World Health Organization (WHO); 2012. 24. Georgiou C. Intraluminal pressure readings during the establishment 12. The International Federation of Gynecology and Obstetrics of a positive ‘tamponade test’ in the management of postpartum (FIGO). FIGO Guidelines: prevention and treatment of postpartum haemorrhage. BJOG. 2010; 117: 295–303. hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;

Hypertens Res Pregnancy 2018; 6: 26–29 29